TRAW
Price:
$2.36
Market Cap:
$11.25M
Traws Pharma, Inc., a clinical stage biopharmaceutical company, focuses on developing small molecule oral product candidates for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID19 that are designed to address treatment resistance, such as TRX01 (travatrelvir), a Mpro/3CL inhibitor in development for the treatment of COVID19; and TRX100 (viroxavir), an endonuclease inhibitor in development for the treatment of pandemic influenza. It is also developing narazaciclib, a multi-kinase CDK4/6 inhibitor, which is in Phase 1/2 clinical trials in patients with cancer, with or without co-administration of letrozole to define the re...[Read more]
Industry
Biotechnology
IPO Date
Stock Exchange
NASDAQ
Ticker
TRAW
According to Traws Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.30. This represents a change of 25.21% compared to the average of -1.04 of the last 4 quarters.
The mean historical PE Ratio of Traws Pharma, Inc. over the last ten years is -1.04. The current -1.30 PE Ratio has changed 12.44% with respect to the historical average. Over the past ten years (40 quarters), TRAW's PE Ratio was at its highest in in the December 2025 quarter at 0. The PE Ratio was at its lowest in in the December 2012 quarter at -164.05.
Average
-1.04
Median
-0.64
Minimum
-3.25
Maximum
-0.25
Discovering the peaks and valleys of Traws Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.18%
Maximum Annual PE Ratio = -0.25
Minimum Annual Increase = -73.01%
Minimum Annual PE Ratio = -3.25
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.25 | -69.65% |
| 2023 | -0.83 | 15.93% |
| 2022 | -0.72 | -73.01% |
| 2021 | -2.66 | -18.33% |
| 2020 | -3.25 | 1.18% |
| 2019 | -0.25 | -39.90% |
| 2018 | -0.42 | -24.52% |
| 2017 | -0.56 | 9.67% |
| 2016 | -0.51 | -43.88% |
| 2015 | -0.91 | -18.62% |
The current PE Ratio of Traws Pharma, Inc. (TRAW) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.60
5-year avg
-1.54
10-year avg
-1.04
Traws Pharma, Inc.’s PE Ratio is less than Cingulate Inc. (-0.00), less than Dogwood Therapeutics, Inc. (-0.31), less than Imunon, Inc. (-0.00), less than Cocrystal Pharma, Inc. (-1.18), less than Sensei Biotherapeutics, Inc. (-0.55), less than Bolt Biotherapeutics, Inc. (-0.24), greater than Mustang Bio, Inc. (-16.20), less than Evogene Ltd. (-0.54), less than BioRestorative Therapies, Inc. (-0.90), greater than Immuron Limited (-2.77),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $22.09M | |
| -0.31 | $11.73M | |
| -0.00 | $10.08M | |
| -1.18 | $10.61M | |
| -0.55 | $13.32M | |
| -0.24 | $10.18M | |
| -16.20 | $9.63M | |
| -0.54 | $9.59M | |
| -0.90 | $9.46M | |
| -2.77 | $8.88M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Traws Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Traws Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Traws Pharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for Traws Pharma, Inc. (TRAW)?
What is the highest PE Ratio for Traws Pharma, Inc. (TRAW)?
What is the 3-year average PE Ratio for Traws Pharma, Inc. (TRAW)?
What is the 5-year average PE Ratio for Traws Pharma, Inc. (TRAW)?
How does the current PE Ratio for Traws Pharma, Inc. (TRAW) compare to its historical average?